Skip to main content
Pangen Biotech Inc. logo

Pangen Biotech Inc. — Investor Relations & Filings

Ticker · 222110 ISIN · KR7222110009 KO Manufacturing
Filings indexed 333 across all filing types
Latest filing 2024-11-13 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 222110

About Pangen Biotech Inc.

https://pangen.com/layout/eng/home.php

Pangen Biotech Inc. is a biotechnology company specializing in the research, development, and manufacturing of biopharmaceuticals. The company utilizes its proprietary platform technologies, particularly those based on Chinese Hamster Ovary (CHO) cell lines, for the production of complex protein therapeutics. Its primary business activities include the development of a pipeline of biosimilar products, such as Erythropoietin (EPO) and Aflibercept. In addition to its own product pipeline, Pangen Biotech offers Contract Development and Manufacturing Organization (CDMO) services, providing expertise in cell line development and biopharmaceutical production to other firms. The company also supplies reagents and kits for research applications.

Recent filings

Filing Released Lang Actions
[기재정정]전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. It details the number of shares to be issued, the conversion price, and the updated listing date. This type of filing relates to changes in capital structure and share issuance resulting from debt conversion, which falls under the 'Share Issue/Capital Change' category.
2024-11-13 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party allocated capital increase). It details the number of shares issued, the total amount raised, the payment date, and lock-up information. This falls under the category of share issuance and capital changes.
2024-11-13 Korean
최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system, specifically titled 'Change of Largest Shareholder'. It details the change in the controlling interest of the company 'Pangen' due to a third-party capital increase and share transfer. This type of disclosure is a standard regulatory requirement for public companies to report changes in ownership structure and control, which falls under the 'Regulatory Filings' category as it is a specific corporate disclosure event.
2024-11-13 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company PanGen (주)팬젠, covering the period from 2024.01.01 to 2024.09.30. It contains detailed financial information, business descriptions, and corporate governance data, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details a change in share ownership by Huons Co., Ltd. in Pangen Co., Ltd. due to a stock purchase agreement. This type of filing is a standard regulatory requirement for significant shareholding changes (often referred to as the '5% rule' filing). In the provided taxonomy, 'Major Shareholding Notification' (MRQ) is the correct category for filings that report changes in significant share ownership levels.
2024-11-12 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. This involves the issuance of new shares resulting from the conversion of debt into equity, which directly impacts the company's capital structure. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2024-11-11 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.